Ars Pharmaceuticals Stock Forecast

Sell candidate since Jul 06, 2026 Loss -1.68%

The ARS Pharmaceuticals, Inc. stock price fell by -1.68% on the last day (Tuesday, 7th Jul 2026) from $8.33 to $8.19. During the last trading day the stock fluctuated 4.79% from a day low at $8.14 to a day high of $8.53. The price has been going up and down for this period, and there has been a -17.94% loss for the last 2 weeks. Volume has increased on the last day by 113 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $10.11 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.00 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 11.94% during the next 3 months and, with a 90% probability hold a price between $8.95 and $11.97 at the end of this 3-month period.

SPRY Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has risen 3.15%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ARS Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.30 and $8.82. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for ARS Pharmaceuticals, Inc. stock

ARS Pharmaceuticals, Inc. finds support from accumulated volume at $8.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.390 between high and low, or 4.79%. For the last week, the stock has had daily average volatility of 5.97%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SPRY) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect ARS Pharmaceuticals, Inc. to open at $8.29, and during the day (based on 14 day Average True Range), to move between $7.85 and $8.53, which gives a possible trading interval of +/-$0.680 (+/-8.66%) up or down from last closing price. If ARS Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 8.66% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.02 (2.08%) than the resistance at $8.40 (2.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ARS Pharmaceuticals, Inc. stock A Buy?

The ARS Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe ARS Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.141 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $8.29 ( 1.18%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk